nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Autologous transplantation for multiple myeloma
|
Harousseau, J. -L. |
|
|
19 |
S7 |
p. vii128-vii133 |
artikel |
2 |
Balancing costs and benefits in cancer therapy and prevention
|
Szucs, T.D. |
|
|
19 |
S7 |
p. vii313-vii319 |
artikel |
3 |
Challenges in treating older cancer patients: breast cancer
|
Wildiers, H. |
|
|
19 |
S7 |
p. vii99-vii103 |
artikel |
4 |
Challenges in treating older cancer patients: colon cancer
|
Papamichael, D. |
|
|
19 |
S7 |
p. vii104-vii108 |
artikel |
5 |
Challenges treating older non-small cell lung cancer patients
|
Gridelli, C. |
|
|
19 |
S7 |
p. vii109-vii113 |
artikel |
6 |
Chemoprevention of breast and prostate cancers: where do we stand?
|
Senn, H.J. |
|
|
19 |
S7 |
p. vii234-vii237 |
artikel |
7 |
Chronic lymphocytic leukaemia: a short overview
|
Montserrat, E. |
|
|
19 |
S7 |
p. vii320-vii325 |
artikel |
8 |
Clinical cancer control and prevention. Eliminating tobacco-induced cancers: a worldwide challenge
|
Bettcher, D.W. |
|
|
19 |
S7 |
p. vii230-vii233 |
artikel |
9 |
Combining immunotherapy with classical anticancer therapy
|
Zwierzina, H. |
|
|
19 |
S7 |
p. vii252-vii255 |
artikel |
10 |
Editorial Board
|
|
|
|
19 |
S7 |
p. ii-v |
artikel |
11 |
Endometrial cancer: adjuvant treatment of endometrial cancer—radiotherapy, chemotherapy or both
|
Reed, N. |
|
|
19 |
S7 |
p. vii67-vii69 |
artikel |
12 |
Erythropoetic-stimulating agents: where do we stand?
|
Dicato, M. |
|
|
19 |
S7 |
p. vii137-vii140 |
artikel |
13 |
ESMO Education
|
|
|
|
19 |
S7 |
p. vii5-vii7 |
artikel |
14 |
ESMO Educational and Scientific activites
|
|
|
|
19 |
S7 |
p. vii10-vii11 |
artikel |
15 |
ESMO Fellowship Program
|
|
|
|
19 |
S7 |
p. vii13-vii15 |
artikel |
16 |
ESMO-MORA
|
|
|
|
19 |
S7 |
p. vii8-vii9 |
artikel |
17 |
European Society for Medical Oncology Committees
|
|
|
|
19 |
S7 |
p. vii17-vii18 |
artikel |
18 |
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers
|
Stupp, R. |
|
|
19 |
S7 |
p. vii209-vii216 |
artikel |
19 |
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours
|
Elez, E. |
|
|
19 |
S7 |
p. vii146-vii152 |
artikel |
20 |
How and why to perform a geriatric assessment in clinical practice
|
Terret, C. |
|
|
19 |
S7 |
p. vii300-vii303 |
artikel |
21 |
Imaging in glioma
|
Herholz, K. |
|
|
19 |
S7 |
p. vii207-vii208 |
artikel |
22 |
Inflammation and cancer prevention
|
Puntoni, M. |
|
|
19 |
S7 |
p. vii225-vii229 |
artikel |
23 |
Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer?
|
Bianchini, G. |
|
|
19 |
S7 |
p. vii177-vii183 |
artikel |
24 |
Introducing new molecular technologies into routine clinical cancer care. What new technology and what for?
|
Mackay, J. |
|
|
19 |
S7 |
p. vii173-vii176 |
artikel |
25 |
Introduction
|
Stahel, Rolf A. |
|
|
19 |
S7 |
p. vii22 |
artikel |
26 |
Learning can be fun
|
|
|
|
19 |
S7 |
p. vii327-vii329 |
artikel |
27 |
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy
|
Baumert, B.G. |
|
|
19 |
S7 |
p. vii217-vii222 |
artikel |
28 |
Lung cancer: new opportunities—changing algorithm in staging
|
Weder, W. |
|
|
19 |
S7 |
p. vii28-vii30 |
artikel |
29 |
Management of weight loss and anorexia
|
Hopkinson, J.B. |
|
|
19 |
S7 |
p. vii289-vii293 |
artikel |
30 |
Mucositis in the treatment of haematological malignancies
|
Niscola, P. |
|
|
19 |
S7 |
p. vii141-vii145 |
artikel |
31 |
Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update
|
Poveda, A. |
|
|
19 |
S7 |
p. vii70-vii76 |
artikel |
32 |
Newer opportunities in systemic therapy of lung cancer
|
Rajan, A. |
|
|
19 |
S7 |
p. vii31-vii37 |
artikel |
33 |
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed?
|
Baselga, J. |
|
|
19 |
S7 |
p. vii281-vii288 |
artikel |
34 |
Novel tools in radiotherapy
|
Spoelstra, F.O.B. |
|
|
19 |
S7 |
p. vii294-vii299 |
artikel |
35 |
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options
|
Licitra, L. |
|
|
19 |
S7 |
p. vii200-vii203 |
artikel |
36 |
Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease
|
Giralt, J. |
|
|
19 |
S7 |
p. vii195-vii199 |
artikel |
37 |
Optimizing approaches to head-and-neck cancers Viruses in head-and-neck cancers: prevention and therapy
|
Psyrri, A. |
|
|
19 |
S7 |
p. vii189-vii194 |
artikel |
38 |
Ovarian cancer: front-line standard treatment in 2008
|
Vasey, P.A. |
|
|
19 |
S7 |
p. vii61-vii66 |
artikel |
39 |
Overcoming immunosuppressive mechanisms
|
Widén, K. |
|
|
19 |
S7 |
p. vii241-vii247 |
artikel |
40 |
Perioperative management of pancreatic cancer
|
Heinemann, V. |
|
|
19 |
S7 |
p. vii273-vii278 |
artikel |
41 |
Prognostic factors for multiple myeloma in the era of novel agents
|
Bladé, J. |
|
|
19 |
S7 |
p. vii117-vii120 |
artikel |
42 |
Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer
|
Cervantes, A. |
|
|
19 |
S7 |
p. vii266-vii272 |
artikel |
43 |
Progress in the multidisciplinary treatment of gastrointestinal cancers, impact on clinical practice: peri-operative management of gastro-esophageal cancer
|
Okines, A. |
|
|
19 |
S7 |
p. vii259-vii265 |
artikel |
44 |
33rd ESMO Congress Officers
|
|
|
|
19 |
S7 |
p. vii19-vii20 |
artikel |
45 |
33rd ESMO Congress Officers
|
|
|
|
19 |
S7 |
p. vii326 |
artikel |
46 |
33rd ESMO Congress Organization
|
|
|
|
19 |
S7 |
p. vii21 |
artikel |
47 |
Recent progress in immunotherapy: anti-cancer vaccines, emerging clinical data
|
Dalgleish, A.G. |
|
|
19 |
S7 |
p. vii248-vii251 |
artikel |
48 |
Screening for lung cancer, an ongoing debate
|
Postmus, P.E. |
|
|
19 |
S7 |
p. vii25-vii27 |
artikel |
49 |
State-of-the-art approach in selective curable tumors: bone sarcoma
|
Bielack, S.S. |
|
|
19 |
S7 |
p. vii155-vii160 |
artikel |
50 |
State-of-the-art approach in selective curable tumors: germ cell tumors
|
Rustin, G. |
|
|
19 |
S7 |
p. vii161-vii165 |
artikel |
51 |
State-of-the-art approach in selective curable tumours: soft tissue sarcoma
|
Judson, I. |
|
|
19 |
S7 |
p. vii166-vii169 |
artikel |
52 |
Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer
|
Sternberg, C.N. |
|
|
19 |
S7 |
p. vii91-vii95 |
artikel |
53 |
Table of Contents
|
|
|
|
19 |
S7 |
p. vi-vii |
artikel |
54 |
The changing face of hormonal therapy for prostate cancer
|
Seruga, B. |
|
|
19 |
S7 |
p. vii79-vii85 |
artikel |
55 |
The role of novel drugs in multiple myeloma
|
Dimopoulos, M.A. |
|
|
19 |
S7 |
p. vii121-vii127 |
artikel |
56 |
The treatment of advanced pancreatic cancer: current evidence and future challenges
|
Moore, M.J. |
|
|
19 |
S7 |
p. vii304-vii308 |
artikel |
57 |
Thymic malignancies
|
Smit, E.F. |
|
|
19 |
S7 |
p. vii309-vii312 |
artikel |
58 |
Treament-related diabetes and cardiovascular disease in prostate cancer survivors
|
Smith, M.R. |
|
|
19 |
S7 |
p. vii86-vii90 |
artikel |
59 |
Treatment tailoring based on molecular characterizations
|
Dinh, P. |
|
|
19 |
S7 |
p. vii46-vii50 |
artikel |
60 |
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
|
Johnstone, E.C. |
|
|
19 |
S7 |
p. vii184-vii186 |
artikel |
61 |
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online
|
Čufer, T. |
|
|
19 |
S7 |
p. vii41-vii45 |
artikel |
62 |
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? Treatment decision-making in advanced disease
|
Smith, I.E. |
|
|
19 |
S7 |
p. vii51-vii57 |
artikel |
63 |
Young Oncologists
|
|
|
|
19 |
S7 |
p. vii16 |
artikel |